Real-time enrollment status for this blood clot medication reversal clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 7:50 AM UTC
| NCT Number | NCT05156983 |
| Recruiting Status | Recruiting |
| Condition | Blood clot medication reversal |
| Phase | PHASE3 |
| Target Enrollment | 440 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of August 31, 2026: Clinical trial NCT05156983 is currently recruiting participants. This phase3 study for blood clot medication reversal is actively seeking new participants at 13 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05156983 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05156983 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.